Menu
GWAS Study

Rare SLC13A1 variants associate with intervertebral disc disorder highlighting role of sulfate in disc pathology.

Bjornsdottir G, Stefansdottir L, Thorleifsson G et al.

35110524 PubMed ID
GWAS Study Type
1028957 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

BG
Bjornsdottir G
SL
Stefansdottir L
TG
Thorleifsson G
SP
Sulem P
NK
Norland K
FE
Ferkingstad E
OA
Oddsson A
ZF
Zink F
LS
Lund SH
NM
Nawaz MS
BW
Bragi Walters G
SA
Skuladottir AT
GS
Gudjonsson SA
EG
Einarsson G
HG
Halldorsson GH
BV
Bjarnadottir V
SG
Sveinbjornsson G
HA
Helgadottir A
SU
Styrkarsdottir U
GL
Gudmundsson LJ
PO
Pedersen OB
HT
Hansen TF
WT
Werge T
BK
Banasik K
TA
Troelsen A
SS
Skou ST
TL
Thørner LW
EC
Erikstrup C
NK
Nielsen KR
MS
Mikkelsen S
JI
Jonsdottir I
BA
Bjornsson A
OI
Olafsson IH
UE
Ulfarsson E
BJ
Blondal J
VA
Vikingsson A
BS
Brunak S
OS
Ostrowski SR
UH
Ullum H
TU
Thorsteinsdottir U
SH
Stefansson H
GD
Gudbjartsson DF
TT
Thorgeirsson TE
SK
Stefansson K
Chapter II

Abstract

Summary of the research findings

Back pain is a common and debilitating disorder with largely unknown underlying biology. Here we report a genome-wide association study of back pain using diagnoses assigned in clinical practice; dorsalgia (119,100 cases, 909,847 controls) and intervertebral disc disorder (IDD) (58,854 cases, 922,958 controls). We identify 41 variants at 33 loci. The most significant association (ORIDD = 0.92, P = 1.6 × 10-39; ORdorsalgia = 0.92, P = 7.2 × 10-15) is with a 3'UTR variant (rs1871452-T) in CHST3, encoding a sulfotransferase enzyme expressed in intervertebral discs. The largest effects on IDD are conferred by rare (MAF = 0.07 - 0.32%) loss-of-function (LoF) variants in SLC13A1, encoding a sodium-sulfate co-transporter (LoF burden OR = 1.44, P = 3.1 × 10-11); variants that also associate with reduced serum sulfate. Genes implicated by this study are involved in cartilage and bone biology, as well as neurological and inflammatory processes.

119,110 European ancestry cases, 909,847 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

1028957
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Finland, Denmark, U.K., Iceland
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.